Today: 4 April 2026
Subscribe
Browse Category

Stock Market 21 October 2025

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
21 October 2025
····
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher reported Q3 2025 adjusted earnings of $1.89 per share on $6.05 billion revenue, beating Wall Street estimates. Shares traded near $208, up 8% in a month but still down 20% year-over-year. The company kept its full-year EPS guidance at $7.70–$7.80, slightly below consensus, sending the stock down 1% pre-market. Most analysts rate DHR a “Buy,” with an average price target of $245.
21 October 2025
··
GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

GM Stock Skyrockets 7% as Earnings Beat, EV Strategy U-Turn Fuel Rally

General Motors shares jumped 6–7% to over $61 on October 21 after Q3 earnings and revenue beat estimates and the company raised its 2025 profit outlook. Adjusted EPS reached $2.80, topping forecasts, while revenue hit $48.6 billion. GM also announced a slowdown in its EV rollout, taking a $1.59 billion charge tied to strategic changes. Wall Street sentiment turned more positive, with several analysts raising price targets.
21 October 2025
··
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M shares closed at $154.78 on Oct. 20, up 17.5% year-on-year, after Q3 earnings beat estimates and the company raised full-year guidance. The firm reported adjusted EPS of $2.19 on $6.3 billion revenue and now expects 2025 EPS of $7.95–$8.05. Legal liabilities from PFAS and earplug lawsuits persist, with a key PFAS trial set for late October. Analyst sentiment has improved, with price targets rising to as high as $185.
21 October 2025
··
GE Aerospace Stock Soars After Q3 Blowout: Raises 2025 Outlook Again

GE Aerospace Stock Soars After Q3 Blowout: Raises 2025 Outlook Again

GE Aerospace reported Q3 2025 GAAP revenue of $12.2 billion, up 24% year-over-year, and GAAP EPS of $2.04, beating analyst estimates. The company raised its full-year outlook, now guiding for 2025 adjusted EPS of $6.00–$6.20. Shares jumped 2.7% pre-market and are up about 78% year-to-date. Analysts remain mostly bullish but warn of high valuation and potential risks from tariffs or supply chain issues.
21 October 2025
···
IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank shares jumped nearly 7% to ₹77 on October 20, 2025, after Q2 FY26 net profit rose 75.5% year-on-year to ₹352.3 crore. Net interest income increased 6.8% to ₹5,113 crore, while gross NPAs held at 1.86%. Brokerages raised price targets, with Jefferies moving to ₹85. CEO V. Vaidyanathan said asset quality remains steady and expects further improvement in funding costs.
21 October 2025
·
HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore Enterprises (Nasdaq: HTCR) jumped about 40% in after-hours trading on Oct. 20 after announcing a one-time $0.13 per share dividend, yielding roughly 17.8%. The stock traded near $0.71 on Oct. 21, within a 52-week range of $0.39–$3.38. Q2 2025 results showed $4.7 million revenue and $1.1 million net income, reversing a prior loss. Record date for the dividend is Nov. 10, with payment set for Nov. 17.
21 October 2025
··
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank shares traded near ₹1,380 on October 21, down 0.5% after a 3% drop post-earnings. Q2 net profit rose 5% year-on-year to ₹12,359 crore, but moderated loan growth and a slight uptick in gross NPA weighed on sentiment. The stock remains up about 8.5% year-to-date, outperforming broader indices. Analyst targets range from ₹1,680 to ₹1,800, citing strong margins and asset quality.
21 October 2025
·
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank shares hit a record ₹38.44 on October 21, 2025, after strong Q2 earnings and a surge in trading volumes. Net profit rose 8.2% to ₹351.6 crore, while gross NPA fell to 2.93%. High-net-worth investor Aditya Kumar Halwasiya bought a 0.76% stake during the rally. Brokerages raised targets to ₹42, citing improved fundamentals and steady loan growth.
21 October 2025
··
RRP Semiconductor Stock Skyrockets 57,000%; Sachin Tendulkar Link Debunked

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd shares soared from ₹15 in April 2024 to ₹9,478 on October 21, 2025, locking at the 2% upper circuit. The Bombay Stock Exchange imposed strict trading curbs, citing a price rise “not commensurate with the financials.” RRP denied rumors linking it to Sachin Tendulkar or government land. The company reported only a few crores in profit and has just two employees.
21 October 2025
··
Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex, saved by its workers in 2024, remains financially unstable, with 2025 sales projected below the €35 million break-even point. The glassmaker launched a €5 million public crowdfunding campaign, offering 8% returns, to fund new products and factory upgrades. Director General François Marciano says banks remain cautious until results improve. Employees have cut costs and rotated store shifts to avoid new hires.
21 October 2025
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics shares rose about 17% to $30 after the FDA granted RMAT and Orphan Drug designations to its lead gene-editing programs, BEAM-101 and BEAM-302. Early trial data showed BEAM-302 raised protective AAT levels and BEAM-101 produced durable increases in fetal hemoglobin. Wall Street’s average 12-month price target is $45–46, implying roughly 70–80% upside.
21 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

Weatherford International reported Q3 earnings of $81 million, or $1.12 per share, missing analyst estimates and down from $157 million a year earlier. Revenue dropped 12.6% to $1.232 billion. U.S. stocks ended mixed as the Dow rose 0.5%, the S&P 500 was flat, and the Nasdaq slipped. General Motors raised its forecast, while Netflix fell after missing targets.
21 October 2025
·
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Spero shares closed at $2.29 on Oct. 20, 2025, up 3.6%, after reporting Phase 3 trial results showing oral tebipenem HBr matched IV imipenem in overall success (58.5% vs 60.2%) at IDWeek. The stock has surged over 120% year-to-date, trading between $0.51 and $3.22. GSK plans an FDA submission in Q4. Analyst 12-month targets average $5, but ratings remain mixed following a recent Zacks downgrade.
21 October 2025
···
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune shares jumped 99% to $8.94 on Oct. 20, 2025, after the FDA accepted its resubmitted BLA for lead cancer therapy RP1 plus nivolumab, setting a PDUFA decision date for April 10, 2026. New trial data showed a 44% response rate in acral melanoma. The stock’s rebound follows a 73% plunge in July after an FDA rejection. Market cap stands near $698 million.
21 October 2025
·
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat shares surged 128% to $1.47 on Oct. 20 after a volatile week driven by a short squeeze and heavy trading volumes. The company completed a debt-for-equity swap on Oct. 15, cutting $900 million in debt but diluting shareholders as outstanding shares jumped from 76.7 million to 392 million. Sales and profits continue to fall, and analysts remain broadly bearish.
21 October 2025
·
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix shares closed at $1,238.56 on Oct. 20, up 3.3% and near all-time highs ahead of Q3 earnings. Analysts expect Q3 revenue of about $11.5 billion and EPS of $6.9–7.0, with focus shifting to advertising and margins. Netflix ended Q2 with 302 million paid subscribers and $2.3 billion in free cash flow. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
21 October 2025
··
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs shares surged nearly 20% on Oct. 20, closing at $15.50 after Q3 results and rare-earth exploration plans. The company posted Q3 revenue of $4.73 billion and an adjusted loss of $0.45 per share, narrower than expected. Executives credited new U.S. steel tariffs for stronger demand and multi-year auto contracts. The stock is up about 42% year-to-date, far outpacing peers.
21 October 2025
·
1 … 1,295 1,296 1,297 1,298 1,299 … 1,371

Stock Market Today

  • Corn Futures Edge Lower Ahead of Long Weekend Amid Export Slowdown
    April 4, 2026, 12:45 PM EDT. Corn futures fell slightly ahead of the long weekend as traders booked profits. Old crop contracts dipped up to 2 cents while new crop remained steady or marginally higher. May corn dropped 9 ¾ cents and December declined 9 cents this week. The national average cash corn price edged down 2 1/4 cents to $4.12 1/2. Export sales for the week ending March 26 totaled 1.15 million metric tons, down 5.6% from last week and 2% below last year, with Mexico leading purchases. February export volumes hit a monthly record at 6.77 million metric tons. Crude oil jumped $11.94 to $112.06 following geopolitical concerns around the Strait of Hormuz. Markets will be closed Friday for Good Friday, reopening Sunday night as normal trading resumes Monday.
Go toTop